Growth capital
Ackermans & van Haaren also provides growth capital to sustainable companies in various sectors. The Growth capital portfolio represents a consolidated book value of 675 million euros and comprises approximately 20 companies with future growth potential.
Participations (consolidated + equity method)
Ackermans & van Haaren's Growth Capital segment comprises 10 investments in various sectors, some are consolidated in the group's accounts, while others are accounted for by using the equity method) and represent a book value of just over 500 million euros. Agidens and Biolectric are the fully consolidated participations. The participations accounted for via the equity method are: Camlin Fine Sciences, GreenStor, Mediahuis, OMP, Turbo's Hoet Group, V.Group, VKC Nuts and Van Moer Logistics.
Life sciences portfolio (fair value investments)
India & South-East Asia (fair value investments)
Ackermans & van Haaren is developing a presence in the rapidly expanding markets of India and Southeast Asia. We selectively engage in high‑quality opportunities across consumer, healthcare, and other growth sectors. AvH invests directly in a limited number of companies, complemented by commitments to region‑specific funds to broaden access and deepen local networks.